Defence Therapeutics (FRA:DTC) Market Cap : €36.72 Mil (As of May. 26, 2024)

View and export this data going back to 2021. Start your Free Trial

What is Defence Therapeutics Market Cap?

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Defence Therapeutics's share price for the quarter that ended in Dec. 2023 was €1.56. Defence Therapeutics's Shares Outstanding (EOP) for the quarter that ended in Dec. 2023 was 44.47 Mil. Therefore, Defence Therapeutics's market cap for the quarter that ended in Dec. 2023 was €69.37 Mil.

Defence Therapeutics's quarterly market cap declined from Mar. 2023 (€101.93 Mil) to Sep. 2023 (€78.22 Mil) and declined from Sep. 2023 (€78.22 Mil) to Dec. 2023 (€69.37 Mil).

Defence Therapeutics's annual market cap increased from Jun. 2020 (€0.00 Mil) to Jun. 2021 (€160.96 Mil) but then declined from Jun. 2021 (€160.96 Mil) to Jun. 2022 (€54.77 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Defence Therapeutics's Enterprise Value for Today is €37.50 Mil.

Defence Therapeutics Market Cap Historical Data

The historical data trend for Defence Therapeutics's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Defence Therapeutics Market Cap Chart

Defence Therapeutics Annual Data

Trend

Jun20

Jun21

Jun22

Market Cap

160.96

54.77

Defence Therapeutics Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Sep23	Dec23
Market Cap	Get a 7-Day Free Trial										43.33	68.70	101.93	78.22	69.37

Competitive Comparison of Defence Therapeutics's Market Cap

For the Biotechnology subindustry, Defence Therapeutics's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Defence Therapeutics's Market Cap Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Defence Therapeutics's Market Cap distribution charts can be found below:

* The bar in red indicates where Defence Therapeutics's Market Cap falls into.

Defence Therapeutics Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

Defence Therapeutics's Market Cap for the fiscal year that ended in Jun. 2022 is calculated as

Market Cap (A: Jun. 2022 )	=	Share Price (A: Jun. 2022 )	*	Shares Outstanding (EOP) (A: Jun. 2022 )
	=	€1.495	*	36.6332
	=	€54.77

Defence Therapeutics's Market Cap for the quarter that ended in Dec. 2023 is calculated as

Market Cap (Q: Dec. 2023 )	=	Share Price (Q: Dec. 2023 )	*	Shares Outstanding (EOP) (Q: Dec. 2023 )
	=	€1.56	*	44.4697
	=	€69.37

Defence Therapeutics (FRA:DTC) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.

Defence Therapeutics Market Cap Related Terms

Thank you for viewing the detailed overview of Defence Therapeutics's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.

Defence Therapeutics (FRA:DTC) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Defence Therapeutics Inc (FRA:DTC) » Definitions » Market Cap

Comparable Companies

Traded in Other Exchanges

DTCFF:USA DTC:Canada

Address

200 Burrard Street, Suite 1680, Vancouver, BC, CAN, V6C3L6

Website

https://www.defencetherapeutics.com

Defence Therapeutics Inc is engaged in the development of a biological drug enhancer platform that improves the efficacy and safety of a multitude of biological/biosimilar-based pharmaceuticals used in the treatment of cancer and infectious diseases. The Company has one operating segment, being research and development.